Search clinical trials for: significant de novo coronary lesion

Total 489506 results

Cardiocentro Ticino
University of Bern

Recruiting

Ticin for the Treatment of Coronary Lesions With Drug Eluting Ballons (TITAN-DEB)

Chronic Coronary Syndrome

Switzerland
Abramson Cancer Center at Penn Medicine

Not yet recruiting

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

Melanoma | Cardiotoxicity | Coronary Microvascular Dysfunction

United States
Advanced MedTech Solutions Pvt. Ltd.

Not yet recruiting

Advapro Coronary Stent System in Coronary Artery Diseased Patients. (RESTORE)

Coronary Artery Disease | Coronary Stent Implantation | De Novo Stenosis Lesion
Concept Medical Inc.
Cardiovascular Research Foundation, New York

Not yet recruiting

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels (MAGICAL-SV)

Cardiovascular Diseases | Coronary Artery Disease | Native Coronary Artery Stenosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

Bail-Out Stenting and Target-vessel Failure After Drug Coated Balloon Coronary percutaneouS Angioplasty for de Novo Lesions (BOSS)

PCI | De Novo Stenosis | DCB

Italy
Xijing Hospital

Recruiting

Intravascular Lithotripsy Versus Conventional Therapy for Severely Calcified Coronary Artery Lesions (REC-CHIPCAC)

De Novo Stenosis | Severely Calcified Coronary Stenoses

China
Xuzhou Third People's Hospital

Not yet recruiting

Yao Strategy for the Treatment of de Novo Medina 0,1,0 or 0,0,1 Bifurcation Lesion

Coronary Artery Disease | Bifurcation Lesion
China National Center for Cardiovascular Diseases

Recruiting

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial (STENTLESS)

De Novo Stenosis | Drug-coated Balloon | Drug-eluting Stent

China
University College, London

Recruiting

Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping (PC-TOX)

Cardiovascular Diseases | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Cardiotoxicity | Malignancy | Oesophagus Cancer | Fluorouracil Adverse Reaction

United Kingdom
Henan Institute of Cardiovascular Epidemiology

Recruiting

Comparison of DCB and DES for Severe Calcification of de Novo Lesion in Elderly CHD

Coronary Artery Disease

China
Chinese University of Hong Kong

Recruiting

Prevail Drug Balloon Study

Myocardial Infarction | Drug-Coated Balloon

Hong Kong
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Drug-coated Balloon Therapy for In-stent Restenosis and de Novo Coronary Lesions

Coronary Heart Disease

China
Advanced NanoTherapies
Monash University; Cardiovascular Research Foundation, New York; Cogent Technologies...

Recruiting

ADVANCEd NanoTherapies Dual Active Pharmacological Ingredient (Dual-API) Drug-Coated Balloon to Treat De-Novo Lesions in Patients With Symptomatic Stable Coronary Artery Disease (ADVANCE-DCB)

Coronary Artery Disease

Australia
General Administration of Military Health, Tunisia
B. Braun Medical International Trading Company Ltd.

Recruiting

Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent (DEBATE)

Coronary Artery Disease (CAD) | De Novo Stenosis | Percutaneous Coronary Intervention (PCI)

Tunisia
Korea University Ansan Hospital
B. Braun Korea Co., Ltd.

Recruiting

STabilization of Atheroma By Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB) (STABLE-DCB)

Coronary Artery Disease | De Novo Stenosis | Atherosclerotic Plaque

Korea, Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Centre Recherche Cardio Vasculaire Alpes

Recruiting

Safety and Efficacy Evaluation of Orbital Atherectomy System in de Novo Calcified Lesions (REFORCE)

Coronary Calcification | Angiography

France
Meshalkin Research Institute of Pathology of Circulation

Recruiting

A Study of Drug Coated Balloon For Treating the Side Branch in Complex Bifurcation Lesions (STENT-FREE)

Coronary Artery Disease

Russian Federation
Samsung Medical Center
Seoul St. Mary's Hospital; Chonnam National University Hospital; Seoul National... and other collaborators

Recruiting

Drug-Coated Balloon in Patients With High Bleeding Risk (DCB-HBR)

Coronary Artery Disease

Korea, Republic of
Minneapolis Heart Institute Foundation

Recruiting

Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions

Percutaneous Coronary Intervention | Target Vessel Failure in Saphenous Vein Grafts

United States
Shenzhen People's Hospital

Not yet recruiting

Resting Full-cycle Ratio-guided Step by Step Balloon Dilation (REDUCE)

de Novo Coronary Lesions
Lepu Medical Technology (Beijing) Co., Ltd.

Not yet recruiting

Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

Coronary Artery Disease | Drug-coated Balloon
M.A. Med Alliance S.A.

Recruiting

The SELUTION DeNovo Study

Coronary Artery Disease

Netherlands, France, Switzerland, Czechia, United Kingdom, Spain, Singapore, Germany, Austria, Italy, Finland, Poland
Liu Bin

Not yet recruiting

Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography

Coronary Artery Disease | Angioplasty

China
Ulsan Medical Center

Recruiting

Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion

Drug-coated Balloon

Korea, Republic of
Nanjing First Hospital, Nanjing Medical University

Not yet recruiting

Safety and Efficacy of DCB Therapy for de Novo Lesions Under the Guidance of QFR in CHD Patients (UNIQUE-DCB-I Study )

Coronary Heart Disease

China
Beijing Hospital

Recruiting

Angioplasty With Paclitaxel-coated Balloon Only Strategy for Coronary de Novo Lesions (DCB-denovo)

Coronary Disease

China
Vejle Hospital
Region of Southern Denmark

Recruiting

Prevention of Chest Pain in Chemo-treated Cancer Patients (CATCH)

Chest Pain | Acute Coronary Syndrome | Cardiotoxicity | Chemotherapeutic Toxicity | Coronary Artery Calcification | Solid Carcinoma | 5-Fluorouracil Toxicity

Denmark
Meshalkin Research Institute of Pathology of Circulation

Recruiting

International Bifurcation Study (IBS)

Coronary Bifurcation Lesion

Russian Federation
Genoss Co., Ltd.

Completed

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

Coronary Artery Disease

Korea, Republic of
University of Colorado, Denver
National Institute on Aging (NIA)

Completed

Advancing Understanding of Transportation Options (AUTO)

Stroke | Multiple Sclerosis | Glaucoma | Brain Injuries | Macular Degeneration | Arthritis | Chronic Obstructive Pulmonary Disease | Parkinson Disease | Restless Legs Syndrome | Diabetic Retinopathy | Insomnia | Retinitis Pigmentosa | Obstructive Sleep Apnea | Dementia | End Stage Renal Disease | Sleep Apnea | Syncope | Seizures and other conditions

United States
Abbott Medical Devices

Completed

Abbott Next Generation Drug Eluting Stent 48mm Study (SPIRIT 48)

Coronary Artery Disease

United States, Australia, Taiwan
Xijing Hospital

Active, not recruiting

Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions

Coronary Artery Disease | De Novo Stenosis

China
InnoRa GmbH

Completed

Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter (SCBDENOVO)

Coronary Artery Disease

Switzerland, Germany
Xijing Hospital

Active, not recruiting

Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions (CAGE-FREEIII)

Coronary Artery Disease | Percutaneous Coronary Intervention | De Novo Stenosis

China
Hospital San Carlos, Madrid
Laboratorios Farmacéuticos Rovi, S.A.; S&H MEDICAL SCIENCE SERVICE, S.L.

Active, not recruiting

Registry of Secondary Revascularization (REVASEC)

Coronary Arteriosclerosis | Stent Stenosis | Coronary Artery Disease Progression | Stent Restenosis | Coronary Artery Disease of Significant Bypass Graft

Spain
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF)

Coronary Artery Disease

China
Sophie JACOB
Institut National de la Santé Et de la Recherche Médicale, France; Clinique... and other collaborators

Completed

BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study (BACCARAT)

Breast Cancer | Cardiac Toxicity

France
Medinol Ltd.

Completed

MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) (JNIR)

de Novo or Restenosis Lesions

Japan
Medinol Ltd.

Completed

NIRTRAKS Post-Market Study (NIRTRAKS) (NIRTRAKS)

de Novo Stenotic Lesions in Native Coronary Arteries

United States
JIMRO Co., Ltd.

Active, not recruiting

Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions

Coronary Artery Disease

Japan
Harbin Medical University
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Active, not recruiting

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS) (DCB-ACS)

Coronary Artery Disease | De Novo Stenosis | Clinical Trial | Acute Coronary Syndromes | ACS | DCB | Drug-Coated Balloon

China
Osamu Ukimura

Active, not recruiting

Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial (PROCRY)

Prostate Cancer

Japan
JW Medical Systems Ltd

Completed

EXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-II)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases

China
JW Medical Systems Ltd

Completed

EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III) (CREDIT-III)

Coronary Artery Disease

China
JW Medical Systems Ltd

Completed

A Pilot First In Man Study of EXCEL-Ⅱto Treat the Patients With de Novo Coronary Artery Lesions (CREDIT)

Ischemia | Coronary Artery Disease

China
Elixir Medical Corporation

Active, not recruiting

The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions

Coronary Artery Disease

New Zealand, Belgium, Netherlands, Czechia, Brazil
Biotronik AG

Active, not recruiting

BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV (BIOSOLVE-IV)

Coronary Artery Disease

Hong Kong, Belgium
Instituto Nacional de Cardiologia Ignacio Chavez
GSE Biomedical; Medstent SA de CV.

Withdrawn

First-in-Man Study: Safety and Efficacy of INC-1 Bare Metal Stent in the Novo Coronary Lesions.

Coronary Artery Disease | Stents | Treatment Outcome | Coronary Angiography | Angioplasty, Balloon, Coronary | Angioplasty | Humans

Mexico
Nanjing First Hospital, Nanjing Medical University

Completed

Comparison of Scoring Balloon and Conventional Balloon Predilation Before Drug Coated Balloon for de Novo Lesion in Patients With High Bleeding Risk (PREPARE-NSE)

Coronary Artery Disease

China

Search clinical trials for: significant de novo coronary lesion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations